Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

71

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

71 results for “amyloid β”

Learn how ShareScore rates datasets ↗
dryad32/100

Data from: Elovanoids counteract oligomeric β-Amyloid-induced gene expression and protect photoreceptors

Open the record for dataset details and reuse information.

publicOct 2019View details →
zenodo28/100

Small molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease

<p>These data describe the&nbsp;bound and unbound ensembles of a disordered peptide (amyloid beta) in the presence and absence of a small, drug-like molecule. The data were produced by metadynamic metainference simulations restrained with NMR chemical shift data. We used PLUMED version 2.6.0 and GROMACS 2018.3. All the data and PLUMED input files required to reproduce the metadynamic metainference results are available on PLUMED-NEST (www.plumed-nest.org), the public repository of the PLUMED consortium, as plumID:20.014.</p> <p>A Jupyter Notebook describing the analysis of these results is available from GitHub at https://github.com/vendruscolo-lab/amyloid-beta_small_mol/ in Metadynamic_metainference/Analysis.</p> <p>These data support the findings of the manuscript entitled &quot;Small molecule sequestration of amyloid-&beta; as a drug discovery strategy for Alzheimer&#39;s disease&quot; by Heller <em>et al</em>. DOI:&nbsp;10.1101/729392</p>

opencc-by-nc-sa-4.0Aug 2019View details →
dryad28/100

Association of amyloid-β CSF/PET discordance and tau load five years later

<p><strong>Objective</strong>: To investigate the association between discordant amyloid-β PET and CSF biomarkers at baseline and the emergence of tau pathology 5 years later.</p> <p><strong>Methods</strong>: We included 730 ADNI participants without dementia (282 cognitively normal, 448 mild cognitive impairment) with baseline [18F]Florbetapir PET and CSF Aβ42 available. Amyloid-β CSF/PET status was determined at baseline using established cut-offs. Longitudinal data was available for [18F]florbetapir (Aβ) PET (baseline to 4.3±1.9 years), CSF (p)tau (baseline to 2.0±0.1 years), cognition (baseline to 4.3±2.0 years), and [18F]flortaucipir (tau) PET (measured 5.2±1.2 years after baseline to 1.6±0.7 years later). We used linear mixed modelling to study the association between amyloid-β CSF/PET status and tau pathology measured in CSF or using PET. Additionally, we calculated the proportion of CSF+/PET- participants who during follow-up (i) progressed to amyloid-β CSF+/PET+, and/or (ii) became tau-positive based on [18F]flortaucipir PET.</p> <p><strong>Results</strong>: Amyloid-β CSF+/PET+ (N=318) participants had elevated CSF (p)tau levels and worse cognitive performance at baseline, while CSF+/PET- (N=80) participants were overall similar to the CSF-/PET- (N=306) group. Five years after baseline, [18F]flortaucipir PET uptake in the CSF+/PET- group (1.20±0.13) did not differ from CSF-/PET- (1.18±0.08, p=0.69), but was substantially lower than CSF+/PET+ (1.48±0.44, p&lt;0.001). Of the CSF+/PET- subjects, 21/64 (33%) progressed to amyloid-β CSF+/PET+, whereas only one (3%, difference p&lt;0.05) became tau-positive based on [18F]flortaucipir PET. </p> <p><strong>Conclusions</strong>: Amyloid-β load detectable by both CSF and PET seems to precede substantial tau deposition. Compared to participants with abnormal amyloid-β levels on both PET and CSF, the CSF+/PET- group has a distinctly better prognosis.</p>

opencc-zeroNov 2021View details →
dryad28/100

Data from: A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity

Aggregation of amyloid-β (Aβ) protein plays a central role in Alzheimer's disease. Because protein aggregation is a concentration-dependent process, rigorous investigations require accurate concentration measurements. Owing to the high aggregation propensity of Aβ protein, working solutions of Aβ are typically in the low micromolar range. Therefore, an ideal Aβ quantification method requires high sensitivity without sacrificing speed and accuracy. Absorbance at 280 nm is frequently used to measure Aβ concentration, but the sensitivity is low with only one tyrosine and no tryptophan residues in the Aβ sequence. Here we present a fluorescence method for Aβ quantification using fluorescamine, which gives high fluorescence upon reaction with primary amines. We show that, using hen egg white lysozyme as a standard, fluorescence correlates linearly with primary amine concentration across a wide range of fluorescamine concentrations, from 62.5 to 1000 µM. The maximal sensitivity of detection is achieved at a fluorescamine concentration of 250 µM or higher. The fluorescamine method is compatible with the presence of dimethyl sulfoxide, which is commonly used in the preparation of Aβ oligomers, and limits the use of absorbance at 280 nm due to its high background reading. Using aggregation kinetics, we show that the fluorescamine method gives accurate concentration measurements at low micromolar range and leads to highly consistent aggregation data. We recommend the fluorescamine assay to be used for routine and on-the-fly concentration determination in Aβ oligomerization and fibrillization experiments.

opencc-zeroDec 2016View details →
dryad28/100

Data from: A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity

Open the record for dataset details and reuse information.

publicJul 2017View details →
dryad28/100

Association of amyloid-β CSF/PET discordance and tau load five years later

Open the record for dataset details and reuse information.

publicNov 2020View details →
dryad28/100

Data from: High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

Open the record for dataset details and reuse information.

publicAug 2019View details →
geo24/100

A Chinese herbal formula, Gengnianchun, ameliorates β-amyloid peptide toxicity in a Caenorhabditis elegans model of Alzheimer’s disease

GEO Series GSE98195. Caenorhabditis elegans. 4 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenFeb 2018View details →
geo24/100

BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides

GEO Series GSE230116. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenApr 2023View details →
geo24/100

Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease [dataset2]

GEO Series GSE263038. Homo sapiens. 3 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenMar 2025View details →
geo24/100

Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology

GEO Series GSE110741. Mus musculus. 96 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2020View details →
geo24/100

TREM2 Drives Microglia Response to Amyloid-β via SYK-dependent and -independent Paths [DAP12KI scRNA-seq]

GEO Series GSE210257. Mus musculus. 7 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenOct 2022View details →
geo24/100

Amyloid-β driven Alzheimer’s disease reshapes the colonic immune system in mice.

GEO Series GSE305697. mouse gut metagenome. 29 samples. Type: Other.

openGEO-OpenSep 2025View details →
geo24/100

TREM2 Drives Microglia Response to Amyloid-β via SYK-dependent and -independent Paths [SYK and TREM2 scRNA-seq]

GEO Series GSE195518. Mus musculus. 17 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenOct 2022View details →
geo24/100

Typical western diet exacerbates dystrophic neurite pathology in APP/PS1 and APP/PS1/Tau mouse models by reducing the clustering of microglia around β-amyloid plaques 

GEO Series GSE144746. Mus musculus. 45 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenNov 2020View details →
geo24/100

Endothelial Cell Senescence Stimulates Amyloid-β Phagocytosis and Barrier Function of Microglia Leading to Attenuation of Cognitive Impairment in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease

GEO Series GSE223394. Mus musculus. 4 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2023View details →
geo24/100

CASP4/Caspase-11 expression exacerbates neuroinflammation and amyloid-β deposition during Alzheimer’s disease [RRBS]

GEO Series GSE227194. Homo sapiens. 10 samples. Type: Methylation profiling by high throughput sequencing.

openGEO-OpenFeb 2024View details →
geo24/100

Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-β accumulation in AppNL-G-F mice

GEO Series GSE279476. Mus musculus. 23 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenNov 2024View details →
geo24/100

Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease [dataset3]

GEO Series GSE263079. Homo sapiens. 32 samples. Type: Other; Expression profiling by high throughput sequencing.

openGEO-OpenMar 2025View details →
geo24/100

Circulating microRNAs associated to cerebrospinal fluid amyloid-β and phosphorylated tau levels as potential non-invasive biomarkers for mild cognitive impairment and Alzheimer’s disease

GEO Series GSE215789. Homo sapiens. 217 samples. Type: Non-coding RNA profiling by high throughput sequencing.

openGEO-OpenFeb 2024View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.